Search company, investor...


Founded Year



Unattributed - III | Alive

Total Raised


Last Raised

$4.26M | 5 mos ago

About Epalex

Epalex is a clinical-stage pharmaceutical company that develops therapies for people with migraines or epilepsy. The company was founded in 2009 and is based in Mountain View, California.

Headquarters Location

1049 El Monte Avenue Suite C 585

Mountain View, California, 94040,

United States


Missing: Epalex's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Epalex's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Epalex

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Epalex is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Epalex Patents

Epalex has filed 11 patents.

The 3 most popular patent topics include:

  • Sedatives
  • General anesthetics
  • Lactams
patents chart

Application Date

Grant Date


Related Topics




Sedatives, Lactams, General anesthetics, Barbiturates, Benzodiazepines


Application Date


Grant Date



Related Topics

Sedatives, Lactams, General anesthetics, Barbiturates, Benzodiazepines



Latest Epalex News

Acute Repetitive Seizures Market Projected to Gain Significant Value through 2021-2031; Increasing Incidents of Epilepsy to Amplify Market Demand

Sep 28, 2021

Search jobs 28-Sep-2021 Acute Repetitive Seizures Market Projected to Gain Significant Value through 2021-2031; Increasing Incidents of Epilepsy to Amplify Market Demand Acute Repetitive seizures are also called recurrent, serial, cluster, crescendo seizures. The Features of Acute repetitive seizures include multiple seizures (more than 3) in less than 24 hours. However the prevalence of acute Repetitive seizures is not known. Acute repetitive seizure occurs due to unusual activities in the brain which may go unseen or it may cause convulsions and unconsciousness due to uncontrolled body shakes. Acute repetitive seizures includes many types of epileptic seizures and can develop at any stage and any age. Fact.MR, A Market Research and Competitive Intelligence Provider recently published a market report which provides an in-depth analysis of the current and future potential of Acute Repetitive Seizures Market.The Market Research Survey highlights the key reasons behind increasing  demand of Acute Repetitive Seizures . The Market Survey also examines the Global Acute Repetitive Seizures Sales for the forecast period 2021- 2031. The report tracks Acute Repetitive Seizures market key trends, growth opportunities and Acute Repetitive Seizures market size. Acute Repetitive seizure Market: Segmentation Tentatively, Acute Repetitive seizure Market has been segmented on the basis of product type, application, and end user. On the basis of Drug Class, Acute Repetitive seizure Market can be segmented as: Benzodiazepines Acute Repetitive seizure Market: Key Players Major market members in the Global Acute Repetitive seizure Market identified across the value chain include:, Valeant Pharmaceuticals, Alexza Pharmaceuticals, Veriton Pharma Limited, Sanofi, Pfizer Inc., Neurelis, UCB S.A., Neurelis, Inc and others. Also there are many emerging therepies from manufacturers such as Acorda Therapeutics, Inc., Upsher-Smith Laboratories, LLC, Epalex and others Key questions answered in Acute Repetitive Seizures Market Survey Report: What is the current scenario and key trends in Acute Repetitive Seizures Market? What are the key strategies companies are adopting to increase their consumer base? What are the key categories within the Acute Repetitive Seizures segments and their future potential? What are the major Acute Repetitive Seizures Market drivers and their expected impact during the short, medium, and long terms? What is the Acute Repetitive Seizures Market size and what are the opportunities for the key players? Essential Takeaways from the this Market Report Comparison of prominent players operating in the market. Recent developments and key strategies adopted by key players. Study of the micro and macro-economic growth indicators. Impact of the various factors on the value chain. Evaluation of current Acute Repetitive Seizures market size, forecast and technological advancements within the industry. Current Insights influencing the scenario and key trends in Acute Repetitive Seizures market. The Report Covers Exhaustive Analysis On: Acute Repetitive Seizures Market Drivers, Segments and Restraints. Acute Repetitive Seizures Market Survey and Dynamics Acute Repetitive Seizures Market Size & Demand Acute Repetitive Seizures Key Trends/Issues/Challenges Acute Repetitive Seizures Sales, Competition & Companies involved Explore Fact.MR’s Coverage on the Healthcare Domain: Digital Therapeutics Market  – According to the latest research by Fact.MR, the digital therapeutics market is set to witness exponential growth during 2021-2031. Increasing adoption for digital health to deliver evidence-based therapeutics will witness a promising growth outlook for digital therapeutics in the long run. Brain Implant Market – According to latest research by Fact.MR, brain implants market is observer stead growth during 2021-2031. Demand for brain implant expects to witness steady recovery in the short-term, with an optimistic growth outlook in the long run. Organ Care Market  – According to the latest research by Fact MR, Organ Care Market is set to witness steady growth during 2021-2031. Demand for the market will witness a steady recovery in the short-term, with an optimistic growth outlook in the long run. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact:

Epalex Frequently Asked Questions (FAQ)

  • When was Epalex founded?

    Epalex was founded in 2009.

  • Where is Epalex's headquarters?

    Epalex's headquarters is located at 1049 El Monte Avenue, Mountain View.

  • What is Epalex's latest funding round?

    Epalex's latest funding round is Unattributed - III.

  • How much did Epalex raise?

    Epalex raised a total of $25.56M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.